Recall Bias: Many of the inclusion/exclusion criteria and RMDQ were susceptible to recall bias, an error that can occur when participants are asked to remember events or experiences for a study.
Explore This Issue
ACEP Now: Vol 36 – No 05 – May 2017Patient Population: Patients were recruited from an urban health care system in a socioeconomically depressed population. Socioeconomic factors may be associated with back pain outcomes, and these results may not necessarily apply to other patient populations.
Unbalanced Groups: Patients in the diazepam arm were more likely to be unemployed. This is a known prognostic factor in recovery in back pain patients.
Blinding: Patients in the benzodiazepine group may have been unblinded. While the authors reported no difference in those feeling dizzy or tired “a lot,” they did not report how many participants felt these side effects “a little.” However, you would expect any lack of blinding to have favored the diazepam group.
Bottom Line
Diazepam should not be routinely added to a NSAID for outpatient management of acute, nontraumatic low back pain patients presenting to the emergency department.
Case Resolution
The man is encouraged to use his naproxen if he feels it provides some benefit, stay active, follow up with his primary care physician, and return to the emergency department if any red flags develop. He also is reassured that symptoms may persist for weeks to months.
Thank you to Anand Swaminathan, MD, MPD, from Core EM and EM:RAP for his help with this review. Dr. Swaminathan is an assistant professor of emergency medicine in the department of emergency medicine at NYU/Bellevue Hospital in New York City.
Remember to be skeptical of anything you learn, even if you heard it on the Skeptics’ Guide to Emergency Medicine.
References
- Williams CM, Maher CG, Latimer J, et al. Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial. Lancet. 2014;384(9954):1586-1596.
- Friedman BW, Dym AA, Davitt M, et al. Naproxen with cyclobenzaprine, oxycodone/acetaminophen, or placebo for treating acute low back pain: a randomized clinical trial. JAMA. 2015;314(15):1572-1580.
- Cantrill SV, Brown MD, Carlisle RJ, et al. Clinical policy: critical issues in the prescribing of opioids for adult patients in the emergency department. Ann Emerg Med. 2012;60(4):499–525.
- Itz CJ, Geurts JW, van Kleef M, et al. Clinical course of non-specific low back pain: a systematic review of prospective cohort studies set in primary care. Eur J Pain. 2013;17(1):5-15.
- Donelson R, McIntosh G, Hall H. Is it time to rethink the typical course of low back pain? PM R. 2012;4(6):394-401;quiz 400.
- da C Menezes Costa LC, Maher CG, Hancock MJ, et al. The prognosis of acute and persistent low-back pain: a meta-analysis. CMAJ. 2012;184(11):E613–E624.
Pages: 1 2 3 4 | Single Page
One Response to “Naproxen, Diazepam Evaluated for Treating Acute, Nontraumatic Low Back Pain”
June 30, 2017
jeff wuBefore we remove another medication from our already anemic quiver in the treatment of back pain, I think we have to be more realistic of the goals of the community ED doc. The conclusion of the authors may be correct based on the parameters of the study, but I disagree with their primary end point, and its application to the actual practice of what we do everyday in the ED.
The study focuses on a change in functional outcome at 1 week and 3 months. I don’t know a single practitioner who believes that any treatment we render for back pain in the ED is improving their long-term outcome. Let’s be honest, we just want them to feel a little better right now. What I would like to see is a study to evaluate the change in pain shortly after taking diazepam. If all we cared about was functional outcome at 1 week and 3 months, we should stop prescribing pain medication for fractures, kidney stones, and other painful conditions–at least until a study shows improvement of long-term functional outcome by treating the associated pain with those ailments.
By the way, Anand notes in his blog that the study had a low inclusion rate and did not control for unemployment rate. Perhaps a better powered study that controlled for those types of variables, and gave us a more meaningful end-point would convince guys like me to change my practice.